This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heininger, U.
Right arrow Articles by Cherry, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heininger, U.
Right arrow Articles by Cherry, J. D.
Related Collections
Right arrow Infectious Disease & Immunity

PEDIATRICS Vol. 100 No. 6 December 1997, p. e10

ELECTRONIC ARTICLE:
Clinical Findings in Bordetella pertussis Infections: Results of a Prospective Multicenter Surveillance Study

Received Jun 13, 1997; accepted Jul 25, 1997.

Ulrich Heininger*, Kerstin Klich*, Klemens Stehr*, and James D. CherryDagger

From * Universitätsklinik mit Poliklinik für Kinder und Jugendliche, Erlangen, Germany; and Dagger  Department of Pediatrics, University of California Los Angeles School of Medicine, Los Angeles, California.

Objective.  To study the clinical presentation of culture-confirmed pertussis in children and their contacts with cough illnesses in an outpatient setting.

Methodology.  In conjunction with a large pertussis vaccine efficacy trial in Germany, a central laboratory to isolate Bordetella species from nasopharyngeal specimens was established in Erlangen in October 1990. Pediatricians in private practices in southern Germany, the Saar region, and Berlin were encouraged to obtain nasopharyngeal specimens and clinical characteristics from patients with cough illnesses >= 7 days' duration. Bordetella species were isolated by use of calcium alginate swabs, Regan-Lowe agar, and modified Stainer-Scholte broth. Clinical characteristics were determined by initial and follow-up questionnaires.

Results.  From October 1990 to September 1996, 20 972 specimens were submitted, and B pertussis was isolated in 2592 instances (12.4%). Of the culture-proven cases, 50.7% were female, and the age range was 6 days to 41 years, with a mean and median of 4.3 years and 4.1 years, respectively. The following characteristics were noted. Only 4% of the patients had received pertussis vaccine. Of unvaccinated patients, 90.2% had paroxysmal cough, 78.9% demonstrated whooping, and 53.3% presented with posttussive vomiting; 5.7% had fever >= 38°C. The duration of cough was <= 4 weeks in 37.9% and <= 3 weeks in 17.4%. Leukocytosis and lymphocytosis (values above the age-specific mean) were observed in 71.9% and 75.9% of unvaccinated patients, respectively. The overall complication rate was 5.8%, and pneumonia (29%) was the most frequent complication. In infants <6 months of age, the rate of complications was 23.8%. One death in a 7-month-old infant occurred.

Conclusions.  Typical symptoms of pertussis were observed in the great majority of patients regardless of age group. However, the duration of cough was surprisingly short in one sixth of the patients. These short illness cases would not be classified as pertussis according to the World Health Organization clinical case definition, which requires >= 21 days of spasmodic cough.

Key words: Bordetella pertussis, surveillance, symptoms, white blood cells.